
zzso B zzso a zzso zzso isolated from a marine zzso has been evaluated in a Phase I zzso The drug was administered in a single intravenous infusion in 150 zzso of normal saline every 30 zzso given every 28 zzso zzso patients received 80 courses of the drug at doses ranging from zzso to zzso zzso The zzso toxicity was zzso and vomiting which began during or shortly after the infusion and was of variable zzso This toxicity was somewhat ameliorated by zzso with an aggressive zzso zzso zzso zzso toxicity also occurred with mild zzso of zzso and zzso One patient experienced an allergic reaction during his second infusion, characterized by zzso zzso zzso and zzso No objective zzso response was seen during this zzso The recommended dose for Phase II studies on a zzso schedule is zzso zzso without zzso zzso and zzso zzso if an zzso regimen is zzso zzso zzso suggest that zzso B is zzso or rapidly converted to a zzso not identified by the zzso used in the zzso Further evaluation will be performed during Phase II zzso 

